CRISPR Therapeutics AG
CRSP NASDAQHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Aug 3, 2026
ET
EPS Est.
-1.19
EPS Actual
-0.94
Revenue Est.
$7.4M
Revenue Actual
$10.2M
Next Earnings Report Date unconfirmed
Date
Nov 9, 2026 · Mon
Time
Time TBD
Fiscal Period
FY2026 Q3
EPS Est.
-1.06
Revenue Est.
$14.8M
Company Overview
CRISPR Therapeutics AG (ticker CRSP) is listed on NASDAQ with a market cap of about $5.74B. Its next earnings report (FY2026 Q3) is expected on Nov 9, 2026 (ET), Time TBD (date pending company confirmation), with consensus EPS of -1.06. In the last 15 reported quarters, EPS beat consensus estimates 10 times.
Actual EPS TrendRecently15Term · Feb 21, 2023 → Aug 3, 2026
Feb 21, 2023Range: -2.40 ~ 1.10Aug 3, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 3, 2026 | -- | -1.19 | Above forecast↑-0.94 | $7.4M | $10.2M |
| May 4, 2026 | -- | -1.19 | -1.28 | $6.1M | $1.5M |
| Feb 12, 2026 | -- | -1.15 | Below forecast↓-1.37 | $4.7M | $864000 |
| Nov 10, 2025 | -- | -1.26 | -1.17 | $9.1M | $889000 |
| Aug 5, 2025 | -- | -1.47 | Below forecast↓-2.40 | $6.1M | $892000 |
| May 6, 2025 | -- | -1.27 | Below forecast↓-1.58 | $6M | $865000 |
| Feb 11, 2025 | -- | -1.15 | Above forecast↑-0.44 | $8.1M | $35M |
| Nov 5, 2024 | -- | -1.33 | Above forecast↑-1.01 | $7.7M | $602000 |
| Aug 5, 2024 | -- | -1.37 | -1.49 | $16.6M | $517000 |
| May 8, 2024 | -- | -1.63 | -1.43 | $3.5M | $504000 |
| Feb 21, 2024 | -- | -0.07 | Above forecast↑1.10 | $28.1M | $200M |
| Nov 6, 2023 | -- | -1.98 | Above forecast↑-1.41 | $8M | -- |
| Aug 7, 2023 | -- | -2.18 | Above forecast↑-0.98 | $1.7M | $70M |
| May 8, 2023 | -- | -1.67 | Above forecast↑-0.67 | $1.7M | $100M |
| Feb 21, 2023 | -- | -2.32 | Above forecast↑-1.41 | $22980 | $6000 |
Original Filings (SEC)
Quarterly10-Q · 2026-08-03 ↗
Earnings Release8-K · 2026-08-03 ↗
Quarterly10-Q · 2026-05-04 ↗
Earnings Release8-K · 2026-05-04 ↗
Annual10-K · 2026-02-12 ↗
Earnings Release8-K · 2026-02-12 ↗
Quarterly10-Q · 2025-11-10 ↗
Earnings Release8-K · 2025-11-10 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
